Comparison of clinical outcomes between non-polymer drug-coated stent versus ultrathin strut biodegradable polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: SMART-CHOICE 4 randomized trial
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0006914
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
1)Subject must be at least 19 years of age
2)Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily.
3)Patients with at least one lesion with equal or greater than 50% diameter stenosis requiring treatment with drug-eluting stents (DES) in native coronary artery or graft
Exclusion Criteria
1)Patients unable to provide consent
2)Patients with known intolerance major components of drug-eluting stents
3)Patients who have non-cardiac co-morbid conditions with life expectancy <1 year or that may result in protocol non-compliance (per site investigator’s medical judgment)
4)Pregnant or lactating women
5) patient with hemodynamic instability or psychogenic shock
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiac death, target vessel-myocardial infarction [MI], or clinically indicated target-lesion revascularization by percutaneous or surgical methods).
- Secondary Outcome Measures
Name Time Method a composite of cardiac death, target vessel-myocardial infarction, or clinically indicated target-lesion revascularization by percutaneous or surgical methods